Concomitant Use of Immunomodulators Affects the Durability of Infliximab Therapy in Children With Crohn’s Disease

Background & Aims It is important to determine the effects of immunomodulators on the ability of children to remain on infliximab therapy for Crohn’s disease (durability of therapy), given the potential benefits and risks of concomitant therapy—especially with thiopurines in male patients. We in...

Ausführliche Beschreibung